Robert DelAversano - 05 Jan 2024 Form 3 Insider Report for Acasti Pharma Inc. (ACST)

Role
Vice President, Finance
Signature
/s/ Robert J. DelAversano
Issuer symbol
ACST
Transactions as of
05 Jan 2024
Transactions value $
$0
Form type
3
Filing time
08 Jan 2024, 08:00:05 UTC
Previous filing
09 Feb 2023
Next filing
08 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACST Stock Options (Right to Buy) 05 Jan 2024 Class A Common Shares 42K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Stock options granted on December 19, 2023 under the Acasti Pharma Inc. Stock Option Plan, which options vest in equal quarterly installments over a period of 36 months.